Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Wertheim

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Haematologica|January 30, 2025
Integrated genomic analysis to reduce chromosomal analysis for the diagnosis of pediatric hematologic malignancies: addressing the shortage of cytogenetic technologistsDong Li, Sarah K Tasian, Gerald Wertheim, et al.
European Journal of Immunology|June 27, 2023
A novel cryopreservation and biobanking strategy to study lymphoid tissue stromal cells in human diseaseJoshua D Brandstadter, Angelina De Martin, Mechthild Lϋtge, et al.
Experimental Hematology|September 30, 2025
Upfront menin-inhibitor resistance in multiply pretreated leukemiasLeila Mahdavi, Fatemeh Alikarami, Haley Goodrow, et al.
Leukemia|March 28, 2025
DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibitionV S S Abhinav Ayyadevara, Gerald Wertheim, Shikha Gaur, et al.
Cold Spring Harbor Molecular Case Studies|March 2, 2022
A novel <i>TP53</i> tandem duplication in a child with Li-Fraumeni syndromeFeng Xu, Erfan Aref-Eshghi, Jinhua Wu, et al.
Blood|May 12, 2016
Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapyVijay G Bhoj, Dimitrios Arhontoulis, Gerald Wertheim, et al.
Blood Advances|November 19, 2019
CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapyVinodh Pillai, Kavitha Muralidharan, Wenzhao Meng, et al.
Cancer Discovery|April 15, 2016
Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic LeukemiaDavid T Teachey, Simon F Lacey, Pamela A Shaw, et al.
Haematologica|February 22, 2024
Genomic profiling of pediatric hematologic malignancies and diagnosis of cancer predisposition syndromes: tumoronly <i>versus</i> paired tumor-normal sequencingHaley Newman, Mary Egan Clark, Derek Wong, et al.
Journal for Immunotherapy of Cancer|April 17, 2025
CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapyRegina M Myers, Amanda M DiNofia, Yimei Li, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Haematologica|January 30, 2025
Integrated genomic analysis to reduce chromosomal analysis for the diagnosis of pediatric hematologic malignancies: addressing the shortage of cytogenetic technologistsDong Li, Sarah K Tasian, Gerald Wertheim, et al.
European Journal of Immunology|June 27, 2023
A novel cryopreservation and biobanking strategy to study lymphoid tissue stromal cells in human diseaseJoshua D Brandstadter, Angelina De Martin, Mechthild Lϋtge, et al.
Experimental Hematology|September 30, 2025
Upfront menin-inhibitor resistance in multiply pretreated leukemiasLeila Mahdavi, Fatemeh Alikarami, Haley Goodrow, et al.
Leukemia|March 28, 2025
DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibitionV S S Abhinav Ayyadevara, Gerald Wertheim, Shikha Gaur, et al.
Cold Spring Harbor Molecular Case Studies|March 2, 2022
A novel <i>TP53</i> tandem duplication in a child with Li-Fraumeni syndromeFeng Xu, Erfan Aref-Eshghi, Jinhua Wu, et al.
Blood|May 12, 2016
Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapyVijay G Bhoj, Dimitrios Arhontoulis, Gerald Wertheim, et al.
Blood Advances|November 19, 2019
CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapyVinodh Pillai, Kavitha Muralidharan, Wenzhao Meng, et al.
Cancer Discovery|April 15, 2016
Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic LeukemiaDavid T Teachey, Simon F Lacey, Pamela A Shaw, et al.
Haematologica|February 22, 2024
Genomic profiling of pediatric hematologic malignancies and diagnosis of cancer predisposition syndromes: tumoronly <i>versus</i> paired tumor-normal sequencingHaley Newman, Mary Egan Clark, Derek Wong, et al.
Journal for Immunotherapy of Cancer|April 17, 2025
CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapyRegina M Myers, Amanda M DiNofia, Yimei Li, et al.
Pageof 5